THE Therapeutic Goods Administration has advised there is a Serious Scarcity Substitution Instrument (SSSI) in place for nicorandil tablets.
Supplies will be in shortage intermittently until Mar 2026, and availability of the 10mg and 20mg strengths of both brands - APO-Nicorandil from Arrotex Pharmaceuticals and Ikotab from Viatris - will vary.
Nicorandil is indicated for the treatment of chronic stable angina pectoris.
The SSSI allows a pharmacist to substitute whichever brand and strength of nicorandil is available, if appropriate, without a new prescription.
If 10mg is prescribed, either brand's 10mg tablets can be dispensed and taken, or 20mg tablets of either brand can be dispensed with half a tablet taken.
For a 20mg prescribed dose, either brand's 20mg tablets can be dispensed and taken, or 10mg tablets can be dispensed with two tablets taken.
Click HERE for more info.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Dec 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Dec 25
